The advanced wound care market was valued at $10.3 billion in 2022, and is estimated to reach $17.8 billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032. Advanced wound care is a specialized and comprehensive approach to manage and treat complex and non-healing wounds. It involves the utilization of innovative wound care products, techniques and technologies that surpass traditional wound care methods, with the objective of promoting more rapid and effective wound healing. This encompassing approach is especially critical for addressing the unique challenges presented by chronic wounds, surgical wounds, burns, traumatic injuries and other intricate wound types. It includes a wide range of interventions, such as specialized wound dressings, biological and bioactive dressings, negative pressure wound therapy and the use of growth factors and cytokines to stimulate tissue repair. Advanced wound care aims to create an optimal wound healing environment, reduce infection risks, improve patient comfort and enhance overall outcomes. It is highly individualized, tailored to the specific needs of the patient and the characteristics of the wound, minimizing complications and ultimately improving the quality of life for those affected by challenging wounds.
The major factors driving the growth of the advanced wound care market include increase in prevalence of chronic wounds, availability of various advanced wound care products and rise in awareness related to advanced wound care among healthcare providers and patients. Chronic wounds, including diabetic ulcers, venous leg ulcers and pressure ulcers, represent a substantial healthcare challenge. For instance, article published by Mary Ann Liebert, Inc., in 2021, stated that, 2% of the total U.S. population are estimated to be affected by chronic wounds. The incidence of chronic wounds is rising owing to several factors such as aging population, increase in chronic diseases such as diabetes and obesity, and other factors. In addition, with the aging global population, there are higher chances of chronic wounds. Older individuals are more susceptible to these types of wounds owing to age-related skin changes, reduced tissue elasticity and slower healing processes.
Furthermore, the prevalence of chronic diseases is on the rise worldwide. Conditions such as diabetes, obesity and cardiovascular diseases often lead to chronic wounds as complications. For instance, diabetes can cause diabetic foot ulcers, which can be challenging to manage and heal. In addition, prolonged hospitalizations are common among patients with chronic illnesses. Extended stays in hospitals or long-term care facilities increase the risk of developing pressure ulcers and other healthcare-associated wounds, further contributing to the demand for advanced wound care products. Moreover, the availability of various advanced wound care products is a crucial factor propelling the market growth. The availability of a wide range of innovative wound care products designed to address the unique challenges of different wound types is expected to drive the market growth. These products offer solutions that go beyond traditional wound care, enabling healthcare providers to provide more effective treatments. Specialized wound dressings are a key category of advanced wound care products. These dressings, include foam dressings, hydrocolloids, hydrogels and alginate dressings, designed for specific wound types, creating an optimal environment for healing and promoting faster tissue repair.
In addition, biological and bioactive dressings, such as bioactive dressings and skin substitutes, contain growth factors and other biologically active substances that enhance tissue regeneration, making them invaluable for the management of chronic and complex wounds. Negative pressure wound therapy (NPWT) is another advanced technique that applies controlled negative pressure to the wound through a vacuum-sealed dressings. This method effectively reduces excess fluid, minimizes swelling and boosts blood flow to the wound, expediting the healing process. Thus, availability of such advanced wound care products is anticipated to drive the market growth.
The advanced wound care market is segmented into product, application, end user and region. On the basis of product, the market is categorized into infection management, exudate management, active wound care and therapy devices. The infection management segment is further divided into silver wound dressings, non-silver dressings and collagen dressings. The exudate management segment is divided into hydrocolloids dressings, foam dressings, alginate dressings and hydrogel dressings. The active wound care segment is divided into Skin Substitutes and growth factors. The therapy devices segment is further bifurcated into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, electromagnetic therapy devices and others.
Based on application, the market is categorized into chronic and acute wounds. The chronic wound segment is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers and arterial ulcers. The acute wound segment is further divided into burns & trauma and surgical wounds. On the basis of end user, the market is segregated into hospital, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global advanced wound care market include ConvaTec Group plc, 3M Company, Cardinal Health Inc., Organogenesis Holdings Inc., Smith & Nephew plc., B. Braun SE, Coloplast, Integra LifeSciences Holdings Corporation, Molnlycke Health Care AB and MIMEDX Group, Inc. The key players have adopted strategies such as acquisition, contract, expansion, product upgrade, funding, product launch and product approval to expand their product portfolio.
The major factors driving the growth of the advanced wound care market include increase in prevalence of chronic wounds, availability of various advanced wound care products and rise in awareness related to advanced wound care among healthcare providers and patients. Chronic wounds, including diabetic ulcers, venous leg ulcers and pressure ulcers, represent a substantial healthcare challenge. For instance, article published by Mary Ann Liebert, Inc., in 2021, stated that, 2% of the total U.S. population are estimated to be affected by chronic wounds. The incidence of chronic wounds is rising owing to several factors such as aging population, increase in chronic diseases such as diabetes and obesity, and other factors. In addition, with the aging global population, there are higher chances of chronic wounds. Older individuals are more susceptible to these types of wounds owing to age-related skin changes, reduced tissue elasticity and slower healing processes.
Furthermore, the prevalence of chronic diseases is on the rise worldwide. Conditions such as diabetes, obesity and cardiovascular diseases often lead to chronic wounds as complications. For instance, diabetes can cause diabetic foot ulcers, which can be challenging to manage and heal. In addition, prolonged hospitalizations are common among patients with chronic illnesses. Extended stays in hospitals or long-term care facilities increase the risk of developing pressure ulcers and other healthcare-associated wounds, further contributing to the demand for advanced wound care products. Moreover, the availability of various advanced wound care products is a crucial factor propelling the market growth. The availability of a wide range of innovative wound care products designed to address the unique challenges of different wound types is expected to drive the market growth. These products offer solutions that go beyond traditional wound care, enabling healthcare providers to provide more effective treatments. Specialized wound dressings are a key category of advanced wound care products. These dressings, include foam dressings, hydrocolloids, hydrogels and alginate dressings, designed for specific wound types, creating an optimal environment for healing and promoting faster tissue repair.
In addition, biological and bioactive dressings, such as bioactive dressings and skin substitutes, contain growth factors and other biologically active substances that enhance tissue regeneration, making them invaluable for the management of chronic and complex wounds. Negative pressure wound therapy (NPWT) is another advanced technique that applies controlled negative pressure to the wound through a vacuum-sealed dressings. This method effectively reduces excess fluid, minimizes swelling and boosts blood flow to the wound, expediting the healing process. Thus, availability of such advanced wound care products is anticipated to drive the market growth.
The advanced wound care market is segmented into product, application, end user and region. On the basis of product, the market is categorized into infection management, exudate management, active wound care and therapy devices. The infection management segment is further divided into silver wound dressings, non-silver dressings and collagen dressings. The exudate management segment is divided into hydrocolloids dressings, foam dressings, alginate dressings and hydrogel dressings. The active wound care segment is divided into Skin Substitutes and growth factors. The therapy devices segment is further bifurcated into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, electromagnetic therapy devices and others.
Based on application, the market is categorized into chronic and acute wounds. The chronic wound segment is further segmented into pressure ulcers, diabetic foot ulcers, venous leg ulcers and arterial ulcers. The acute wound segment is further divided into burns & trauma and surgical wounds. On the basis of end user, the market is segregated into hospital, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global advanced wound care market include ConvaTec Group plc, 3M Company, Cardinal Health Inc., Organogenesis Holdings Inc., Smith & Nephew plc., B. Braun SE, Coloplast, Integra LifeSciences Holdings Corporation, Molnlycke Health Care AB and MIMEDX Group, Inc. The key players have adopted strategies such as acquisition, contract, expansion, product upgrade, funding, product launch and product approval to expand their product portfolio.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced wound care market analysis from 2022 to 2032 to identify the prevailing advanced wound care market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the advanced wound care market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global advanced wound care market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By End User
- Hospitals
- Homecare Settings
- Others
By Product
- Infection Management
- Type
- Silver Wound Dressings
- Non-Silver Dressings
- Collagen Dressings
- Exudate Management
- Type
- Hydrocolloids Dressings
- Foam Dressings
- Alginate Dressings
- Hydrogel Dressings
- Active Wound Care
- Type
- Skin Substitutes
- Growth Factors
- Therapy Devices
- Type
- Negative Pressure Wound Therapy (NPWT)
- Oxygen and Hyperbaric Oxygen Equipment
- Electromagnetic Therapy Devices
- Others
By Application
- Acute Wounds
- Type
- Burns and Trauma
- Surgical Wounds
- Chronic Wounds
- Type
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Smith & Nephew plc
- 3M Company
- B. Braun SE
- Integra LifeSciences Holdings Corporation
- Cardinal Health Inc.
- MIMEDX Group, Inc.
- Molnlycke Health Care AB
- Coloplast
- ConvaTec Group plc
- ORGANOGENESIS HOLDINGS INC.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ADVANCED WOUND CARE MARKET, BY PRODUCT
CHAPTER 5: ADVANCED WOUND CARE MARKET, BY APPLICATION
CHAPTER 6: ADVANCED WOUND CARE MARKET, BY END USER
CHAPTER 7: ADVANCED WOUND CARE MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Smith & Nephew plc
- 3M Company
- B. Braun SE
- Integra LifeSciences Holdings Corporation
- Cardinal Health Inc.
- MIMEDX Group, Inc.
- Molnlycke Health Care AB
- Coloplast
- ConvaTec Group plc
- ORGANOGENESIS HOLDINGS INC.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
